Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares IssuedShares OutstandingShares Repurchased
Ratios

Neurocrine Biosciences (NBIX) Shares Outstanding (2016 - 2025)

Historic Shares Outstanding for Neurocrine Biosciences (NBIX) over the last 15 years, with Q4 2025 value amounting to $100.1 million.

  • Neurocrine Biosciences' Shares Outstanding rose 70.42% to $100.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $100.1 million, marking a year-over-year increase of 70.42%. This contributed to the annual value of $100.1 million for FY2025, which is 70.42% up from last year.
  • As of Q4 2025, Neurocrine Biosciences' Shares Outstanding stood at $100.1 million, which was up 70.42% from $99.7 million recorded in Q3 2025.
  • Neurocrine Biosciences' 5-year Shares Outstanding high stood at $101.2 million for Q3 2024, and its period low was $94.5 million during Q1 2021.
  • Over the past 4 years, Neurocrine Biosciences' median Shares Outstanding value was $99.0 million (recorded in 2025), while the average stood at $98.4 million.
  • As far as peak fluctuations go, Neurocrine Biosciences' Shares Outstanding soared by 338.11% in 2024, and later crashed by 188.31% in 2025.
  • Neurocrine Biosciences' Shares Outstanding (Quarter) stood at $94.8 million in 2021, then increased by 4.11% to $98.7 million in 2023, then grew by 0.71% to $99.4 million in 2024, then increased by 0.7% to $100.1 million in 2025.
  • Its Shares Outstanding was $100.1 million in Q4 2025, compared to $99.7 million in Q3 2025 and $99.0 million in Q2 2025.